The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment-Reference-Cited by-同舟云学术

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Published:2005 Issue:1 Volume:54 Page:26-37
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Breedveld Ferdinand C.,Weisman Michael H.,Kavanaugh Arthur F.,Cohen Stanley B.,Pavelka Karel,Vollenhoven Ronald van,Sharp John,Perez John L.,Spencer-Green George T.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference64 articles.

1. Rheumatoid arthritis

2. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis

3. The course of radiologic damage during the first six years of rheumatoid arthritis

4. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage

Cited by 1510 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and cellular contributors of Rheumatoid Arthritis;International Journal of Drug Discovery and Pharmacology;2024-08-29

2. Network Pharmacology and Experimental Validation Explore the Pharmacological Mechanisms of Herb Pair for Treating Rheumatoid Arthritis;Combinatorial Chemistry & High Throughput Screening;2024-08

3. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

4. Anti-TNF Alpha and Risk of Lymphoma in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis;Medicina;2024-07-17

5. A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDs;Rheumatology and Therapy;2024-07-08